Methylation-Specific Differentiation of Vaginal Epithelial Cells for Forensic Tissue Typing by Bisulfite Conversion and Pyrosequencing by Pood, Elise
The University of Southern Mississippi 
The Aquila Digital Community 
Master's Theses 
Spring 2019 
Methylation-Specific Differentiation of Vaginal Epithelial Cells for 
Forensic Tissue Typing by Bisulfite Conversion and 
Pyrosequencing 
Elise Pood 
University of Southern Mississippi 
Follow this and additional works at: https://aquila.usm.edu/masters_theses 
 Part of the Biology Commons, and the Genetics and Genomics Commons 
Recommended Citation 
Pood, Elise, "Methylation-Specific Differentiation of Vaginal Epithelial Cells for Forensic Tissue Typing by 
Bisulfite Conversion and Pyrosequencing" (2019). Master's Theses. 641. 
https://aquila.usm.edu/masters_theses/641 
This Masters Thesis is brought to you for free and open access by The Aquila Digital Community. It has been 
accepted for inclusion in Master's Theses by an authorized administrator of The Aquila Digital Community. For 
more information, please contact Joshua.Cromwell@usm.edu. 
METHYLATION-SPECIFIC DIFFERENTIATION OF VAGINAL EPITHELIAL 
CELLS FOR FORENSIC TISSUE TYPING BY BISULFITE CONVERSION AND 
PYROSEQUENCING 
 
 
by 
 
Elise Nicole Pood 
A Thesis 
Submitted to the Graduate School, 
the College of Arts and Sciences 
and the School of Criminal Justice, Forensic Science, and Security 
at The University of Southern Mississippi 
in Partial Fulfillment of the Requirements 
for the Degree of Master of Science 
Approved by: 
 
Dr. Kuppareddi Balamurugan, Committee Chair 
Dr. Philip Carlan 
Dr. Dean Bertram 
 
 
 
 
 
 
 
 
 
 
____________________ ____________________ ____________________ 
Dr. Kuppareddi 
Balamurugan 
Committee Chair 
Dr. Lisa Nored 
Director of School 
Dr. Karen S. Coats 
Dean of the Graduate School 
 
May 2019 
  
COPYRIGHT BY 
Elise Nicole Pood 
2019 
Published by the Graduate School  
 
 
 ii 
ABSTRACT 
The identification of bodily fluids and tissues is often applied to criminal 
investigations to clarify events that may or may not have taken place.  Current forensic 
techniques can identify blood, saliva, seminal fluid, and spermatozoa, but there is a clear 
absence of reliable testing to identify vaginal epithelial tissue.  Though there are 
serological tests available for this purpose, tissue-specific methylation markers have 
recently been investigated as a candidate for the identification of blood, saliva, and 
spermatozoa. 
In this study, tissue-specific methylation markers were analyzed to identify a set 
of markers for the differentiation of vaginal fluid from blood, saliva, and semen.  From 
the four tissue types collected, genomic DNA was extracted, quantitated, and bisulfite-
modified to preserve the methylation information.  Candidate markers were amplified 
then pyrosequenced to determine the percent methylation of specific CpG sites.  The 
level of significance between tissues was determined using one way ANOVA Tukey’s 
posthoc test by SPSS statistical package. 
Three markers, cg4739647, cg6266993, and cg9323727 were found to be 
hypermethylated in vaginal fluid compared to blood, saliva, and semen.  The differences 
between methylation levels at nearly all analyzed CpG sites were found to be significant, 
suggesting that these markers may be used to identify vaginal epithelial tissue for 
forensic purposes.  Pyrosequencing has several advantages over conventional serological 
analysis, and the development of a multiplex kit using these markers will aid in the 
conservation of precious DNA samples that can be used for other forensic purposes. 
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CHAPTER I - INTRODUCTION 
Current DNA Technology 
Within the scope of scientific advancement, the application of DNA technology to 
human identification is still relatively young.  There is recent, rapid progress in many 
facets of human identification using DNA technology.  Prior to 1985, Forensic Biology 
essentially relied on ABO blood typing, a method of discriminating between individuals 
based on the antigens present on their red blood cells.  This method was developed by 
Karl Landsteiner in the early 1900s (Landsteiner, 1901), and improvements upon 
Landsteiner’s blood typing method included MN typing and Rh factor identification 
(Landsteiner and Wiener, 1940).  Comparison of red and white blood cell enzymes were 
later found to have a higher rate of discrimination between individuals than blood typing 
alone and were often used for clarification in paternity cases.  The first Restriction 
Fragment Length Polymorphism (RFLP) was discussed by Ray White and colleagues in 
1980 (Botstein et al., 1980), though it was not until 1985 that Alec Jeffreys released his 
discovery of the first probe for human identification (Gill et al., 1985).  Alec Jeffreys was 
also credited for using RFLP DNA technology for the first time in a criminal case to 
convict Colin Pitchfork of sexual assault and murder (Butler, J. M. 2010).  The Variable 
Number Tandem Repeat (VNTR) analysis was considered the gold standard in forensic 
analysis but this process had its own disadvantages as well.  The need for a larger 
quantity of DNA (100+ ng) as well as high molecular weight DNA complicated the 
analysis in cases where there was limited DNA available (10ng or less).  Often the DNA 
available for casework is severely degraded and is not suitable for VNTR analysis.  These 
two disadvantages associated with RFLP technology generated the need for a more robust 
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technology where small amounts of DNA could be used to obtain a complete DNA 
profile.  The identification of Short Tandem Repeat (STR) polymorphism (Edwards et al., 
1991) and the invention of Polymerase Chain Reaction (PCR) (Saiki RK, 1985) have 
overcome the two major disadvantages with RFLP analysis.  This transition of 
technologies happened around 1995 and by 2000 nearly all labs in the country had 
validated the use of STR markers for forensic casework. 
In 1985 Kary Mullis, a scientist at Cetus Corporation, released his development of 
PCR technology (Saiki RK, 1985) which allows small quantities of genomic DNA to be 
amplified quickly and easily.  This advancement circumvented the previous need for 
high-quality, undegraded DNA for VNTR analysis, and allowed even relatively-degraded 
samples in low quantities to be used without deleterious effect to results.  The PCR 
technique revolutionized not only the field of human identification but impacted most 
biological disciplines that were reliant upon DNA for advancement. 
In criminal cases involving biological evidence, the presence or absence of tissue 
types such as blood, semen, saliva, or vaginal secretions can be a crucial component for 
understanding the events that transpired during the reported crime.  Unfortunately, 
methods for tissue identification have not seen similarly rapid advancements as those 
pertaining to human identification (Patzelt, 2004). 
Current Tissue ID Methods 
Several serological tests exist for the detection of human body fluid.  These tests 
are employed by forensic professionals in the field and in the laboratory and are generally 
delineated into two groups—presumptive and confirmatory tests.  Presumptive tests are 
often used in the field to suggest the presence of a bodily fluid, and they tend to have a 
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high level of sensitivity but lack the species-specificity.  Confirmatory tests are used to 
authenticate the presumed presence of a bodily fluid but can tend to be less sensitive than 
presumptive tests and may offer false negative results in diluted stains.  For example, the 
presumptive Phenolphthalein test employed in the identification of blood is highly 
sensitive and can detect more than 1000-fold dilution of blood, while the confirmatory 
test for blood, the Takayama crystal test is sensitive only up to a 50-fold dilution of 
blood. 
The presumptive tests for blood identification include the Kastle-Meyer test and 
the Hemastix test while the confirmatory test relies on the identification of hemoglobin 
crystals in the sample.  The presumptive test for seminal fluid depends on the presence of 
excessive amounts of Acid Phosphatase enzyme while the confirmatory tests depend on 
microscopic identification of spermatozoa or detection of Prostate Specific Antigens 
(PSA) in the sample.  The identification of saliva is based on the detection of excessive 
amounts of the enzyme Amylase that is also found in other tissues as well in smaller 
quantities.  Current tests for presumptive and confirmatory tissue identification possess 
numerous disadvantages such as expending exorbitant amounts of the available sample, 
possessing high rates of false positives or negatives under such common circumstances as 
dilutions, and lacking specificity for species identification or even differentiation between 
similar tissues.  Additionally, no standard protocol exists for the differentiation of vaginal 
epithelial cells or vaginal fluid from other tissues commonly encountered in forensic 
casework.  Development of a simultaneous method for accurate and reliable 
differentiation of forensically-relevant tissues would reduce the time necessary for 
serological processes during casework and minimize the expenditure of available 
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evidentiary samples.  So, a more reliable method of tissue identification becomes 
necessary for serological analysis of evidence. 
DNA Methylation 
All nucleated cells in humans contain identical genetic sequences, but the 
chemical changes to the DNA nucleotides within each cell, referred to as the epigenetic 
modifications, differ widely (Ng & Gurdon, 2008).  Epigenetic modifications include 
histone modification, chromatin remodeling, gene silencing or activation, and 
carcinogenesis, but one of the most common and well-studied epigenetic modifications is 
methylation.  Methylation is the addition of a methyl group (CH3) at the 5-carbon of the 
Cytosine (C) ring resulting in 5-methylcytosine (5mC) (Kader & Ghai, 2015).  (Figure 1). 
 
 Methylation of a Cytosine 
Addition of a methyl group to the 5-C position of cytosine (Chakarov et al., 2014). 
Since the methylation occurs in the Cytosine that is immediately followed by a 
Guanine (G), they are usually referred to as CpG sites.  In human DNA, 5-methylcytosine 
is found in approximately 1.5% of genomic DNA (Lister et al., 2009).  While methylation 
typically occurs at a CpG site, some non-CpG methylation has been reported in humans 
(Kader & Ghai, 2015).  The body employs methylation often in the promoter regions of 
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genes (Figure 2) to regulate expression in different areas of the genome in different cells, 
as necessary (Patterson et al., 2011). 
 
 Activation and inactivation of a gene via methylation. 
When a CpG island in the promoter region of a gene is methylated, expression of the gene is repressed (Reynolds, Jacobson, & Drake, 
2013). 
Methylation can occur in response to environmental stimuli in utero and 
throughout the individual’s lifetime (Lee et al., 2012), but is often associated with X-
inactivation, genetic memory, and cell fate (Madi et al., 2012).  Methylation is often 
found in areas known as CpG islands, which are clusters of CpG sites that typically exist 
within the promoter region of a gene and contain high GC percentages.  The expression 
of genes is regulated by methylation interfering with the binding of ribosomes to the 
promoter region of genes (Gardiner-Garden and Frommer, 1987).  Numerous genome-
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wide studies have indicated a relationship between DNA methylation and certain regions 
of the genome of a specific tissue known as tissue-specific differentially methylated 
regions (tDMRs) (Vidaki et al., 2016; Lee et al., 2012).  Earlier Eckhardt et al. (2006) 
reported the high-resolution DNA methylation profile of human chromosomes 6, 20, and 
22 and provided a resource of DNA methylation for 12 different tissues.  The use of 
DNA methylation-based forensic tissue identification using methylation-sensitive 
restriction enzymes was reported by Frumkin et. al. (2011).  In this study, the authors 
differentiated blood, saliva, semen, and skin cells based on the methylation pattern of the 
tissues.  Lee et al. (2012) reported the identification of CpG site-specific methylation 
information for semen, blood, and vaginal fluid using the Illumina HumanMethylation 
450K BeadChip array.  Other studies have reported the identification of semen-specific 
methylation patterns (Wasserstrom et. al., 2013). 
Bisulfite Modification 
Direct genomic sequencing of post-PCR samples does not reveal the methylation 
status of CpG sites, since the methylation information is lost during PCR; conversions 
such as bisulfite modification may be used to protect and reveal methylation status of 
CpG sites.  Bisulfite modification converts unmethylated cytosine nucleotides to uracil, 
which are converted to thymine during the subsequent PCR process.  The methylated 
cytosines are protected from such conversion and remain as cytosine (Figure 3).  The 
bisulfite-modified DNA is then PCR amplified and pyrosequenced at single-nucleotide 
resolution to determine the methylation status of specific CpG sites.  The percentage of 
methylation for an unknown tissue is calculated by comparing the percentage of cytosine 
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nucleotides that have been converted to thymine nucleotides in the sample (Patterson et. 
al. 2011). 
 
 Bisulfite Modification of Unmethylated vs. Methylated DNA 
(DNA methylation: a guide, 2017). 
Methods to Measure DNA Methylation 
Several technologies have been utilized to quantitate the percentage of 
methylation within certain regions of the genome.  One of these methods is ligation-
mediated PCR, which utilizes a pair of non-isoschizomeric restriction enzymes, one of 
which is methylation-sensitive.  The cleavage by the methylation sensitive enzyme is 
quantitated by amplifying the restricted products with ligation-mediated PCR and 
radioactive labeling.  The amplified product ratios of the two digested products are 
compared and correlate directly to the amount of methylation present in the restriction 
site (McGrew & Rosenthal, 1993). 
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The single-nucleotide resolution of capillary electrophoresis sequencing can be 
applied to methylation analysis studies as well.  Small amounts of DNA undergo 
enzymatic hydrolyzation to single nucleotides which are then derivatized with a 
fluorescent marker, followed by capillary electrophoresis.  Corresponding strands known 
to be fully-methylated and fully-unmethylated are analyzed separately to establish a 
reference for methylation, then the DNA in question is compared with the reference to 
derive its percent methylation (Stach et al., 2003). 
Other studies for DNA methylation analysis include digestion of genomic DNA 
using methylation-sensitive restriction enzymes.  Many restriction enzymes are sensitive 
to DNA methylation and cleavage of the restriction site may be impaired if a base 
involved in the restriction site is modified.  In this experiment, the genomic DNA is 
digested with methylation-sensitive restriction enzymes and amplified using 
fluorescently-labeled primers that flank the restriction site.  If the DNA fragment is 
cleaved by the enzyme (non-methylated site), there is no amplification.  If the DNA 
fragment is not cleaved by the enzyme, the target segment is amplified (methylated site) 
(Frumkin et. al. 2011). 
Pyrosequencing 
Pyrosequencing is one of the many sequencing technologies that offers single-
nucleotide resolution necessary for measuring methylation.  Pyrosequencing is a 
“sequence-by-synthesis” technique.  Genomic DNA undergoes bisulfite conversion, 
followed by PCR amplification of the target region containing CpGs for which 
information about methylation levels is desired.  Biotinylated PCR products are generated 
by tagging one of the PCR primers with Biotin, a necessary step before pyrosequencing.  
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The amplified products are bound to streptavidin beads and treated with an alkali to result 
in single-stranded DNA.  To initiate a pyrosequencing reaction, a sequencing primer is 
hybridized to a single-stranded template and incubated with appropriate enzymes.  
Nucleotides are dispensed according to each assay’s individual dispensation order.  In the 
presence of a complimentary base, a dNTP is ligated onto the template strand by DNA 
polymerase and the incorporation results in a flash of light from the photoluminescent 
chemicals.  The pyrosequencer records which nucleotide was incorporated, and the 
amount of light emitted before degrading the unused dNTP’s and moving to the next 
nucleotide on the template strand.  The results of each sample are displayed as a 
pyrogram with the relative methylation levels of each CpG site in the target segment.  
Pyrosequencing is a reliable, sensitive method for methylation analysis in both hyper-and 
hypomethylated regions (Tost & Gut, 2007; Madi et. al. 2012).  Pyrosequencing 
technology is advantageous in that the methylation information is quantified for each 
CpG site.  The differential methylation pattern of specific sites can be determined for a 
variety of tissues and the resulting percent methylation can be used to identify the tissue 
source of a DNA sample.  Once a set of epigenetic markers is identified, this technology 
can be routinely used in crime labs to differentiate one tissue from others. 
Aims and Objectives 
The primary purpose of this study is to identify a set of DNA methylation markers 
that can be used to differentiate vaginal epithelial cells from three other forensically-
relevant tissues (blood, saliva, and semen) for forensic human identification, based on the 
relative percent methylation of the target CpG sites.  This will be accompanied by 
genomic DNA extraction, bisulfite conversion of genomic DNA, PCR amplification of 
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target segments using site-specific PCR primers, and finding the relative percent 
methylation of the target segments in different tissues by quantitative pyrosequencing.  
The development of a set of markers for vaginal epithelial cell identification could be 
combined with the known markers for several forensically-relevant tissues to develop a 
multiplex kit for serological analysis.  A multiplex tissue identification kit could reduce 
the time and resources currently being applied to the serological process in forensic 
laboratories. 
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CHAPTER II – REVIEW OF LITERATURE 
Current Presumptive and Confirmatory Tissue ID Methods 
RSID 
Discrimination between forensically-relevant body fluids such as blood, saliva, 
and semen has seen some recent advancement with the development of the Rapid Stain 
Identification Series (RSID) confirmatory tests, which utilize secretion-specific antigens 
to confirm the presence of specific tissues or bodily fluids.  The principle of the RSID 
test strips is similar to that of the ABAcard Hematrace test, where an 
immunochromatographic strip is impregnated with antihuman antibodies that are specific 
to each bodily fluid and have no cross-specificity with each other (Casey & Price, 2010). 
Blood 
One commonly used test for the presumptive detection of blood is the 
phenolphthalein, or Kastle-Meyer test.  The colorless phenolphthalin reagent, in a 
reduced, alkaline state, when mixed with blood and hydrogen peroxide, turns pink to 
indicate the possible presence of blood.  The pink color is a result of the oxidation 
reaction carried out by the peroxidase-like activity of hemoglobin in presence of 
hydrogen peroxide.  Though the Kastle-Meyer test is useful in the field for rapid 
presumptive identification of blood, false positive reactions have been reported for a 
myriad of other substances, including vegetable extracts, nasal mucus, saliva, and milk 
(Gaensslen, 1983).  The sensitivity of the phenolphthalein test makes it one of the 
preferred reagents among a plethora of other tests. 
Chemiluminescent tests such as Luminol are frequently used in field for the 
presumptive identification of blood.  Luminescence is achieved by the oxidation of the 
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luminol compound by the hemoglobin in blood.  Luminol possesses an advantage of 
fewer false positive reactions than phenolphthalein-based tests, but some studies have 
shown it to interfere with subsequent serological analyses.  The Luminol test is widely 
used in the field where the presence of blood is suspected but not visible.  These 
presumptive tests are very sensitive but lack specificity to humans (Gaensslen, 1983). 
If the presence of blood has been inferred by field-testing, serological 
confirmatory testing is utilized prior to subjecting the evidence for DNA analysis.  The 
Takayama crystal test is one such confirmatory method.  Pyridine ferroprotoporphyrin or 
hemochromogen crystals are produced by heating a mixture of heme and an alkaline 
solution of pyridine, in presence of a reducing sugar.  These pink-colored, feather-shaped 
crystals (Figure 4) can be viewed under a microscope and their presence is inferred as a 
positive test for blood (James et al., 2005).  The reaction relies upon the presence of 
hemoglobin only, resulting in the Takayama crystal test’s non-specificity for human 
blood. 
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 Pink colored, feather shaped Takayama hemochromogen crystals. 
(Image courtesy-K. Balamurugan) 
The ABAcard Hematrace test strip is another confirmatory method that is 
considered mostly specific for humans but has been reported to give false positives for 
some animal blood (Ferret).  A partially-diluted aqueous sample is placed in the sample 
window, where the strip has been treated with mobile antihuman hemoglobin antibodies 
that bind to any human hemoglobin antigens present in the sample.  The antibody-antigen 
complex and attached dye molecule migrate to the testing window portion of the strip that 
has been treated with an immobilized antihuman hemoglobin antibody.  The antigen-
antibody complex binds in the testing window to the immobilized antibody.  A single 
antibody-antigen-antibody complex is undetectable to the naked eye, but a pinkish line 
appears as more and more of these complexes aggregate in the test area.  An internal 
control line appears separately to denote a functional test even in the absence of blood.  
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Though largely specific for humans, the ABAcard has been shown to give false positives 
for the blood of ferrets and some primates (Reynolds M., 2004). 
For the rapid identification of blood, the RSID-blood test identifies the presence 
of glycophorin-A, an antigen found in the cell membrane of red blood cells.  The test also 
shows no inhibition by field presumptive test reagents such as Luminol (Turrina et. al. 
2008). 
Saliva 
The most common semi-quantitative approach for identifying the presence of 
saliva is the radial diffusion test.  For radial diffusion, gel plates containing starch are 
prepared with multiple wells with a template attached to the back of the plate.  Unknown 
evidentiary samples, known saliva standards, and non-saliva standards such as blood, 
urine, and semen are pipetted into the wells separately and the plate is incubated to allow 
the digestion of the starch within the gel to occur.  After incubation, the plates are treated 
with iodine to stain remaining starch within the gel.  Areas where a clear circle is 
observed indicate amylase activity, and the size of the clear area is directly proportional 
to the amount of amylase contained within the corresponding body fluid.  Radial 
diffusion test is highly presumptive and non-species specific (Haltiner, 2008). 
For rapid detection of saliva, the RSID-saliva test detects the presence of the ɑ -
amylase enzyme present in salivary secretions.  Currently-used tests detect the presence 
of amylase activity, such as the starch iodine radial diffusion test or the Phadebas test, 
both of which rely on ɑ -amylase digestion of starches in the tests and are interpreted by 
the absence or presence of a dark blue color (Myers & Adkins, 2008).  The RSID-saliva 
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test detects the actual presence of ɑ-amylase antigens as opposed to their activity against 
starch (Casey & Price, 2010). 
Semen 
Several tests exist for the presumptive identification of seminal fluid.  One 
method to detect the presence of semen is the acid phosphatase (AP) test.  Acid 
phosphatase is an enzyme that is secreted into semen in high quantities by the prostate 
gland.  The test relies on Alpha-Napththyl acid phosphate reacting with Brentamine Fast 
Blue dye in the presence of AP to rapidly produce a purple color.  The AP test is no more 
than a presumptive test due to the presence of acid phosphatase in other bodily fluids, 
including vaginal fluid.  Additionally, AP outside of the body degrades rapidly when 
exposed to heat and humidity (Noureddine, 2011).  The standard confirmatory test for 
seminal fluid is the microscopic observation of spermatozoa using the Christmas tree 
staining technique.  The stain consists of Kernechtrot (Nuclear Fast Red) and 
Picroindigocarmine (green) dyes that stain the sperm nuclei and acrosomal regions red, 
while staining the tail and neck portions greenish-blue.  Though this confirmatory test is 
extremely effective for the identification of spermatozoa, it lacks efficacy for the 
identification of seminal fluid from males with a compromised sperm count 
(oligospermic) or ejaculatory fluid that may contain little or no spermatozoa 
(azoospermic) (Noureddine, 2011). 
For the detection of semen, the RSID series includes a test for semenogelin, 
which is a human-specific antigen produced only in seminal vesicles and excreted in 
seminal fluid.  Validation tests were performed to successfully rule out false positives in 
saliva, urine, breast milk, serum, and vaginal fluid, as well as species-specificity against 
 16 
equine, canine, swine, and bovine semen samples (Sato et al., 2004).  The Abacard 
Onestep PSA test kit (Abacus diagnostics, CA) is also available commercially to detect 
the semen-specific antigens.  This test is based on the human-specific prostate antigens 
reacting with anti-human prostate antibodies, producing a colored band in the test kit. 
Vaginal epithelial cells 
Though there are many methods for the identification of seminal fluid, saliva, and 
blood, there are no currently-implemented standard confirmatory methods for the 
identification of vaginal epithelial tissue or vaginal secretions.  Many of the existing 
technologies, such as mRNA profiling, molecular identification of microbial signature, 
and protein markers are still in the validation stage. 
mRNA profiling 
Several techniques involving mRNA profiling have surfaced, including one that 
combines mRNA with bacterial markers for a more comprehensive identification of 
vaginal fluid.  Though the efficacy of this method has been shown, it requires additional 
steps not typically taken in a forensic laboratory and can consume portions of the sample 
that may have otherwise been used for DNA identification.  Researchers also noted the 
variability of both individual vaginal microbiomes and expression of the targeted mRNA 
(Jakubowska et al., 2013), leading to some uncertainty regarding the reliability of this 
method.  Giampaoli et al. added that mRNA in vaginal samples are highly unstable in the 
best of laboratory storage conditions and can degrade in as little as two weeks 
environmentally (Giampaoli et al., 2012), making mRNA profiling an unrealistic option 
for cases in which the evidence is not collected and processed rapidly. 
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Microbiome Differentiation 
Giampaoli et al. studied the microbial signature of vaginal flora to differentiate 
vaginal fluid from other body fluids.  Though the results are promising for vaginal, oral, 
and anal sample differentiation based on the abundance of characteristic bacteria for each 
orifice, the technique becomes significantly less-applicable in the presence of mixtures or 
in the case of trace samples (Giampaoli et al., 2012).  The microbiome analysis technique 
could be additionally problematic, as it does not specifically identify the presence of a 
bodily fluid or tissue, but infers its presence based on the bacteria associated with those 
areas of the body. 
Protein-based assays, such as the RSID and PSA tests, are commonly used, but 
suffer many similar drawbacks as microbiome and mRNA analysis.  Protein-based assays 
are neither highly specific nor sensitive and are unstable under environmental conditions 
(Harbison & Fleming, 2016).  Furthermore, the use of these assays requires a large 
amount of sample be consumed with little probative return. 
Methylation-Based Tissue Differentiation 
A study by Frumkin et al. was among the first with promising results for the 
differentiation of blood, saliva, semen, and skin tissues based on DNA methylation 
levels.  The researchers used a methylation-specific restriction enzyme PCR technique to 
prepare samples for capillary electrophoresis.  The ratios of percent methylation were 
calculated by comparing the low electropherogram signals for hypomethylation with the 
high signals associated with hypermethylation.  This method allowed for successful 
discrimination between the tissue types (Frumkin et al., 2011). 
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A subsequent study by Lee et al. tested five tissue-specific differentially 
methylated regions (tDMRs) for differentiating blood, saliva, semen, menstrual blood, 
and vaginal fluid via bisulfite conversion and DNA sequencing through capillary 
electrophoresis.  Though their results suggested two markers for the use of semen 
identification, they also noted that some of the tDMRs could be used in conjunction with 
each other to identify the presence of menstrual blood and/or vaginal fluid.  Additionally, 
the study suggests that the methylation profiles of these tDMRs remain consistent in 
samples aged for 30 days at room temperature (Lee et al., 2012).  In two similar studies, 
An et al. reported similar results regarding identification of vaginal fluid and menstrual 
blood (An et al., 2013).  A review by Kader and Ghai suggests the necessity of further 
studies to identify more robust markers that can distinguish between vaginal fluid and 
menstrual blood (Kader & Ghai, 2015). 
In a comprehensive study of global DNA methylation profiles, Park et al. utilized 
the Illumina HumanMethlation 450K bead array to assess the methylation values of 
450,000 CpG sites.  From the resulting methylation data, researchers identified two CpG 
sites per tissue for robust differentiation of blood, saliva, semen, and vaginal fluid.  
Additional potential CpG sites that can be used to differentiate tissues were also provided 
(Park et al., 2014). 
Recently, Antunes et al. published a study specifically testing a small section of 
the PFN3-PFN3A marker that Lee et al. (2012) previously revealed for its use in 
discrimination of vaginal fluid.  The study utilized bisulfite conversion and 
pyrosequencing to investigate the data from Lee et al.  The researchers tested the assay 
for mixture and species specificity, with largely successful results, but they highlight the 
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necessity of identifying further locations with improved sensitivity for vaginal epithelial 
discrimination (Antunes et al., 2016). 
Pursuant to the line of testing performed by Antunes et al., we seek to identify a 
set of markers for further investigation into novel CpG sites to distinguish vaginal 
epithelial cells from other relevant tissue types.  CpG sites with notable differences in 
percent methylation of vaginal epithelial cells in relation to other tissues, as described by 
their beta values (Park et al., 2014) are considered candidates for investigation. 
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CHAPTER III  - MATERIALS AND METHODS 
Sample Collection 
Blood, buccal cells, vaginal epithelial cells, and semen samples were collected 
under an IRB-approved protocol for a previous, related study and were available in the 
laboratory. 
Blood 
Samples were collected from volunteers by cleaning the volunteer’s fingertip with 
absolute ethanol, then applying a lancet device to the fingertip of the volunteer.  Blood 
was squeezed from the fingertip onto sterile cotton swabs.  The swabs were air-dried, 
placed in labeled paper envelopes, and stored at -20°C until extraction. 
Buccal 
Saliva samples were collected from volunteers by providing the volunteers with 
sterile cotton swabs and instructing the volunteers to firmly swab the inside of the cheek 
for one minute.  The swabs were air-dried, placed in labeled paper envelopes, and stored 
at -20°C until extraction.  
Semen 
Semen samples were collected from male volunteers by providing a specimen cup 
and instruction for deposit and return of sample.  Volunteers were instructed to avoid 
sexual contact prior to sample collection.  Sample cups were labeled and stored at -20°C 
until extraction. 
Vaginal Epithelial 
Vaginal epithelial samples were collected from female volunteers by providing 
sterile cotton swabs and instruction for collection and return of sample.  Volunteers were 
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instructed to wait several days after sexual contact or menstrual activity before collecting 
the sample.  Swabs were air-dried, placed in labeled paper envelopes, and stored at -20°C 
until extraction. 
DNA Extraction and Quantitation 
Standard organic DNA extraction procedures were performed on all samples 
(Budowle et al., 2000).  The swab portion of buccal, blood, and vaginal epithelial 
samples were cut from the swab stick and placed in individually labeled 1.5mL tubes 
with 400µL of stain extraction buffer and 10µL of proteinase K (20mg/mL).  The samples 
were incubated overnight at 56°C.  Semen samples were extracted by combining 25µL of 
sample in individually labeled 1.5mL tubes with 150µL of TNE (Tris-HCL, NaCl, 
EDTA), 50µL of 20% Sarkosyl, 40µL of 0.39M DTT (dithiothreitol), 150µL of diH2O, 
and 10µL of proteinase K.  The samples were incubated at 56°C overnight.  After 
incubation, the cotton swab material was placed in a Spin-X basket in each 1.5mL tube 
and centrifuged at 16,000 rcf for five minutes to force any liquid out of the material and 
into the tube.  The Spin-X basket and swab material were removed and discarded.  
500µL of phenol/chloroform/isoamyl alcohol were added to each tube, vortexed 
to obtain a milky emulsion, and centrifuged for 10 minutes at 16,000 rcf to separate the 
aqueous and organic phases.  The aqueous phases were pipetted into Amicon100 Ultra 
centrifugal filter devices (Millipore Corporation, Bedford, MA), and centrifuged for 10 
minutes at 2,300 rcf.  After centrifugation, approximately 400µl of Tris-EDTA (TE) 
buffer were added to the column and centrifuged for 10 minutes at 2,300 rcf.  This 
washing process was repeated three additional times before collection of the purified 
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DNA.  The purified DNA was collected by inverting the filter unit in a clean 1.5ml tube 
and centrifuging at 600 rcf for 3 minutes.  The DNA was stored frozen until further use.  
Agarose gel (1%) was utilized to obtain both quantitative and qualitative 
information for the DNA samples (Budowle et al., 2000).  1µL of sample and 2µL of 
bromophenol blue (BPB) loading dye were loaded into wells of a 1% agarose gel 
containing ethidium bromide.  The gel was electrophoresed in 1x TAE (Tris/Acetic 
Acid/EDTA) buffer at 120V for 20 minutes.  Samples were visualized with a UV 
Transilluminator.  The gel images were photographed and stored in a computer. 
Bisulfite Conversion 
Bisulfite conversion was performed on genomic samples using the Qiagen 
EpiTect® Bisulfite Kit with manufacturer’s recommendations (Qiagen Inc). 
1. Bisulfite reaction components were added to 0.2mL PCR tubes based on the 
concentration of genomic DNA identified in each sample via gel electrophoresis.  
The components and volumes of individual reagents for bisulfite conversion are 
described in Table 1. 
Component Volume per reaction (µL) 
DNA solution (1 ng-2 µg) Variable* (maximum 20 µL) 
RNase-free water Variable* 
Bisulfite Mix (dissolved) 85 
DNA Protect Buffer 35 
Total volume 140 
Table 1. Bisulfite reaction components 
*The combined volume of DNA and RNase-free water is 20µL. 
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2. After a brief vortex and quick spin, the samples were placed in a thermal cycler. 
3. The samples underwent a three-stage denaturation and incubation process: 
a.  The samples were denatured at 95°C for 5 minutes, then incubated at 
60°C for 25 minutes. 
b. The samples were denatured at 95°C for 5 minutes, then incubated at 
60°C for 85 minutes. 
c. The samples were denatured at 95°C for 5 minutes, then incubated at 
60°C for 175 minutes. 
4. The samples were held at 20°C until they were removed from the thermal cycler 
and subjected to a cleanup process to remove the bisulfite conversion reagents and 
purify the converted DNA. 
Bisulfite Conversion Cleanup Process 
1. The PCR tubes were removed from the thermal cycler and the bisulfite reactions 
were transferred to clean 1.5mL tubes. 
2. 560µL of loading buffer (Buffer BL) containing 10µL of carrier RNA were added 
to each tube, and samples were vortexed and centrifuged briefly at 16,000 rcf. 
3. Samples were transferred to EpiTect® DNA spin columns with collection tubes 
and centrifuged for 1 minute at 16,000 rcf. 
4. The flow-through was discarded, and 500µL of wash buffer (Buffer BW) was 
added to the spin columns. 
5. Samples were centrifuged at 16,000 rcf for 1 minute, and the resulting flow-
through was discarded. 
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6. 500µL desulphonation buffer (Buffer BD) was added, followed by incubation at 
room temperature for 15 minutes. 
7. Samples were centrifuged for 1 minute at 16,000 rcf and the resulting flow-
through was discarded.   
8. 500µL of wash buffer (BW) was added, followed by 1 minute of centrifugation at 
16,000 rcf.  The resulting flow through was discarded. 
9. The washing step using buffer BW (step 8) was repeated once. 
10. The columns were transferred to new 2mL tubes and centrifuged for another 
minute, then incubated for 5 minutes at 60°C with open lids to encourage ethanol 
to dissipate.  
11. To elute the converted DNA from the spin columns, the columns were placed in 
clean 1.5mL tubes, and 20µL of eluting buffer was pipetted directly onto the 
column membrane. 
12. The tubes were allowed to incubate for 1 minute at room temperature, then eluted 
via centrifugation at 16,000 rcf. 
13. Tubes containing the bisulfite converted DNA were stored at -20°C until use. 
CpG Marker Selection and Primer Design 
The prospective markers were chosen from data provided in Park et al., 2014, 
which detailed a list of potential CpG sites that may be used to differentiate vaginal 
epithelial cells from other tissues.  CpG sites with notable differences in hyper- or 
hypomethylation of vaginal epithelial cells in relation to other tissues, denoted by beta 
values, were considered candidates for investigation.  Selected CpG site information, 
such as the location of the marker in a chromosome and its position in the genomic DNA, 
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was entered into the University of California Santa Cruz (UCSC) Genome Browser using 
the human genome assembly build 37 (GRCh37/hg19).  After locating the CpG site 
within the human genome, a sequence of approximately 200 bases on both the 5’ and, 
3’side was downloaded.  This downloaded sequence was used to design primers for PCR 
amplification and sequencing using the Pyromark assay design software (Qiagen).  Three 
CpG markers were selected after screening a pool of candidate markers.  The primer 
specifications are listed in Appendix A.  
Polymerase Chain Reaction (PCR) 
Bisulfite-converted DNA from at least seventeen samples of each tissue type, 
blood, buccal cells, sperm, and vaginal epithelial tissue were chosen for PCR 
amplification using the designed PCR primers.  PCR components per sample are detailed 
in Table 2. 
Bisulfite-converted DNA 2 µL 
10x PCR Primer set 2 µL 
Coral load solution 2 µL 
Q-solution 4 µL 
2x PCR Master mix 10 µL 
Reaction Volume: 20 µL 
Table 2. PCR components per sample for sample amplification 
Negative controls were included to check for contamination in reagents.  
Annealing temperatures were determined by subtracting 5°C from the melting 
temperatures (Tm) of the forward and reverse primers.  The PCR cycling conditions for 
the amplification are detailed in Table 3. 
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Initial  
Incubation Step 
Denaturation Annealing Extension Final 
Extension 
Final Soak 
HOLD CYCLE (45 cycles) HOLD HOLD 
95ºC 
15 min 
94ºC 
30 sec 
Tm-5ºC 
30 sec 
72ºC 
30 sec 
72ºC 
10 min 
4ºC 
∞ 
Table 3.  PCR cycling conditions for sample amplification. 
To check the robustness of amplification, a 2% agarose gel quantitation was 
utilized.  2µL of amplified products was pipetted into each well of the gel, 
electrophoresed at 120V for 20min, and visualized using a UV Transilluminator. 
Pyrosequencing 
Pyrosequencing assays were created using the PyroMarkQ24 software.  Twenty-
four bisulfite-converted samples that had undergone amplification and quantitation were 
selected for each pyrosequencing run. 
Amplified samples were arranged in three rows of eight per the assay design, then 
18µL of PCR product was aliquoted into each well of a multi-well tray containing 62µL 
of pyrosequencing cocktail (2µL streptavidin beads, 40µL binding buffer, 20µL diH2O).  
The multi-well tray was covered with strip caps and shaken on a microplate shaker at 
1000 rpm for 10 minutes.  After removing the plate from the shaker and removing the 
strip caps, the PCR products attached to the streptavidin beads were lifted using a 
vacuum pump and processed using the PyroMark Q24 workstation.  The streptavidin 
beads and PCR products were released onto a pyrosequencing plate containing 25µL of 
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1x sequencing primer in each well.  The plate was incubated on a hot plate at 80°C for 2 
minutes, then allowed to rest at room temperature for 10 minutes. 
The pyrosequencing cartridge was prepared with enzyme, substrate, and dNTPs in 
amounts determined by the PyroMark Q24 software.  The samples underwent 
pyrosequencing in the PyroMark Q24 pyrosequencer as per manufacturer’s protocol.  
Once sequencing was completed, the Pyromark software was used to analyze the percent 
methylation of each CpG site. 
Data Analysis 
After data collection was complete, the methylation data of individual CpG sites 
for all samples for a marker was entered in an Excel spread sheet, grouping each tissue 
separately.  Mean percent methylation and standard deviation values were calculated by 
averaging the methylation values at each CpG site for each group of tissues tested.  Mean 
methylation values of the different tissues were compared using a one-way ANOVA and 
Tukey’s Post Hoc pair-wise comparisons to determine if there were statistically-
significant differences between the mean methylation values of the tissues studied.  
Methylation differences were considered statistically significant when p- values were less 
than 0.05 (p<0.05).  Statistical analysis for the significant difference in percent 
methylation level between tissues was determined by SPSS software package version 22 
(IBM) (Balamurugan et al., 2014). 
Bisulfite Controls 
Bisulfite conversion controls were present in each assay to ensure appropriate 
levels of bisulfite conversion within samples.  The bisulfite conversion process changes 
all unmethylated cytosines to thymine; a control is implemented by selecting a cytosine 
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that is not part of a CpG site, so the unmethylated cytosine will convert fully to thymine.  
When the sample is pyrosequenced, the results should indicate complete conversion of 
the control site ‘C’ to ‘T’.  A control site that retains any percentage of unconverted 
cytosines is indicative of incomplete bisulfite modification.  Samples that failed the 
bisulfite control were rejected due to incomplete conversion.
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CHAPTER IV – RESULTS 
DNA quantity estimates were made by comparing the intensity of DNA standards 
and the samples.  Figure 5 shows a gel image of the extracted DNA samples with a 1KB 
ladder for comparison. 
 
 1% agarose gel quantitation of genomic DNA. 
The gel image was used to roughly estimate the amount of genomic DNA 
necessary for bisulfite conversion.  Seventeen bisulfite-converted DNA samples for each 
tissue type per marker were used to amplify the target segment containing multiple CpG 
sites.  Figure 6 shows the agarose gel quantitation of PCR product from one of the unused 
markers. 
 
 2% agarose gel quantitation of PCR products 
Vaginal epithelial marker 5167251. 
Most of the samples amplified produced the expected size of amplicons.  In some 
of the agarose gel images, primer dimers were identified by the observation of fluorescent 
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bands smaller than the target amplicon size.  These are largely either non-specific 
amplification or primer dimers.  The presence of primer dimers did not affect the quality 
of the pyrosequencing results. 
The pyrosequencing results were analyzed using the Pyromark Q24 software and 
the resulting data were displayed as pyrograms.  Figures 7 and 8 show pyrograms for 
samples that are hypermethylated and hypomethylated, respectively. 
 Hypermethylated Pyrogram 
Vaginal epithelial marker cg-9323727, vaginal epithelial sample 112.  
The CpG sites that were analyzed for this marker are indicated by the shaded area 
with percent methylation displayed above the shaded box.  At the first CpG site, the 
percent methylation recorded by the pyrosequencer was 67%.  This means that 67% of 
the cytosines at this site were methylated, with the remaining unmethylated. 
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 Hypomethylated Pyrogram 
Vaginal epithelial marker cg-9323727, blood sample 36. 
 In Figure 8, at CpG site 1, the percent methylation recorded by the pyrosequencer 
was zero.  This means that this site was completely unmethylated. 
 The reagent blanks used during DNA extraction were also used for PCR to check 
for any possible reagent contamination.  Figure 9 shows the pyrogram of a reagent blank 
for vaginal epithelial marker cg-4739647 with no detectable peaks. 
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 Reagent Blank Pyrogram 
Vaginal epithelial marker cg-4739647, sample reagent blank. 
 If no amplifiable DNA is present in the sample, the results are displayed as a flat 
line as opposed to individual peaks.  
 If a band was identified in the reagent blank well of agarose quantitation, the 
reagent blank was pyrosequenced to determine whether the band was a primer dimer or 
contamination.  If no band was identified in the agarose quantitation, one reagent blank 
was pyrosequenced per marker to ensure a lack of contamination in pyrosequencing 
reagents. 
Vaginal Epithelial Marker 4739647 
Of the samples pyrosequenced for the epigenetic marker 4739647, 11 blood, 18 
buccal, 14 vaginal epithelial, and 13 sperm samples provided viable data for analysis.  
Percent methylation data per CpG site for all samples was recorded in an excel spread 
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sheet and average standard deviations were calculated with the appropriate formula 
within the spreadsheet.  Table 4 shows the percent methylation averages and values per 
tissue type of each CpG site for marker cg4739647. 
  CpG 
1 
CpG 
2 
CpG 
3 
CpG 
4 
CpG 
5 
CpG 
6 
CpG 
7 
CpG 
8 
CpG 
9 
 
Blood 
Avg. 13 6 9 8 9 8 10 8 11 
Std. 
Dev. 
15.7 6.7 13.6 12.7 13.7 11.7 13.4 12.3 16.1 
 
Buccal 
Avg. 20 21 15 14 19 16 17 14 14 
Std. 
Dev. 
10.7 14 12.2 10.6 14.9 11.9 13.2 11.4 11.2 
Vaginal 
Epithelial 
Avg. 42 44 41 37 42 39 44 37 34 
Std. 
Dev. 
18.4 23.2 17.5 17.6 21.5 16.9 23 16.8 14.6 
 
Sperm 
Avg. 10 9 10 8 9 8 10 8 8 
Std. 
Dev. 
13.2 11.6 13.4 10.9 11.4 11.3 12.1 11.1 9.95 
Table 4. Percent Methylation Averages and Standard Deviations-Marker 4739647 
Percent methylation averages and standard deviations arranged by tissue type and CpG site.  
Figure 10 shows the average methylation data and corresponding standard 
deviations for individual CpG sites for all tissues for the v.epi. marker 4739647. 
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 Histogram for 4739647 
Average methylation data for all four tissues studied for the vaginal epithelial marker 4739647. Bars above each data indicate standard 
deviation. 
Statistical analysis of the mean methylation values for vaginal epithelial tissue in 
comparison with blood, buccal, and sperm tissues was performed using a one-way 
ANOVA and Tukey’s HSD test.  The significance values for each tissue as compared to 
vaginal epithelial for marker 4739647 are shown in Table 5. 
v.epi. 4739647 
        
 
CpG1 CpG2 CpG3 CpG4 CpG5 CpG6 CpG7 CpG8 CpG9 
Blood 0 0 0 0 0 0 0 0 0 
Buccal 0.002 0.002 0 0 0.002 0 0 0 0 
Sperm 0 0 0 0 0 0 0 0 0 
Table 5. Levels of significance (p) for 4739647 
For all CpG sites of v. epi marker compared to other tissues. 
The p values of all CpG sites of v. epi. marker 4739647 were found to be below 
0.05, indicating significant difference in percent methylation values.  The epigenetic 
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marker 4739647 was found to differentiate vaginal epithelial cells from blood, buccal, 
and sperm cells (p<0.05). 
Vaginal Epithelial Marker 6266993 
Of the samples pyrosequenced for the epigenetic marker 6266993, 14 blood, 11 
buccal, 12 vaginal epithelial, and 12 sperm samples provided viable data for analysis.  
Percent methylation data for all CpG sites were recorded and averaged by tissue type.  
Table 6 shows the percent methylation average and standard deviation values for all CpG 
sites for the marker 6266993. 
  CpG 1 CpG 2 CpG 3 CpG 4 
 
Blood 
Avg. 9 5 8 5 
Std. Dev. 13.3 8.8 10.9 6.6 
 
Buccal 
Avg. 25 20 28 19 
Std. Dev. 27.2 28.4 24 26.5 
Vaginal 
Epithelial 
Avg. 48 43 40 51 
Std. Dev. 24.7 24 20 25.7 
 
Sperm 
Avg. 2 2 6 3 
Std. Dev. 3.1 1 3.8 3 
Table 6. Percent Methylation Averages and Standard Deviations-Marker 6266993 
In Figure 11, the percent methylation averages and standard deviation values were 
organized into a histogram to visualize the correlations.  
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 Histogram for 6266993 
Average methylation data for all four tissues studied for the vaginal epithelial marker 6266993. Bars above each data indicate standard 
deviation. 
Statistical analysis of the mean methylation values for vaginal epithelial tissue in 
comparison with blood, buccal, and sperm tissues was performed using a one-way 
ANOVA and Tukey’s HSD test.  The level of significance for each tissue as compared to 
vaginal epithelial are shown in Table 7. 
v. epi. 6266993 
   
 
CpG1 CpG2 CpG3 CpG4 
Blood 0 0 0 0 
Buccal 0.038 0.03 0.316 0 
Sperm 0 0 0 0 
Table 7. Levels of significance (p) for 6266993 
For all CpG sites of v. epi marker compared to other tissues. 
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The p values of all CpG sites of v. epi. marker 6266993 were found to be below 
0.05 except CpG 3, indicating significant difference in percent methylation values.  The 
epigenetic marker 6266993 was found to differentiate vaginal epithelial cells from blood, 
buccal, and sperm cells (p<0.05) for the samples tested except for CpG 3 (p>0.05). 
Vaginal Epithelial Marker 9323727 
Of the samples pyrosequenced for the epigenetic marker 9323727, 9 blood, 12 
buccal, 9 vaginal epithelial, and 11 sperm samples provided viable data for analysis.  
Percent methylation for all CpG sites was recorded and averaged for all samples.  
Standard deviations for each CpG site for all tissues were calculated.  Table 8 shows the 
percent methylation averages and standard deviation values for all CpG sites tested for 
marker 9323727. 
  CpG 1 CpG 2 CpG 3 CpG 4 CpG 5 
 
Blood 
Avg. 2 6 8 8 14 
Std. Dev. 4 6 8.9 9.9 30.7 
 
Buccal 
Avg. 6 10 11 10 13 
Std. Dev. 4.9 7.3 7.1 5.7 8.8 
Vaginal 
Epithelial 
Avg. 40 49 47 38 37 
Std. Dev. 27.4 30.7 30.8 26.6 26.24 
 
Sperm 
Avg. 3 4 4 3 5 
Std. Dev. 2.5 4.4 3.7 3.1 4.6 
Table 8. Percent Methylation Averages and Standard Deviations-Marker 9323727 
Figure 12 shows the relative percent methylation averages and standard deviation 
values for all sites tested for the marker 9323727.  
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 Histogram for 9323727 
Average methylation data for all four tissues studied for the vaginal epithelial marker 9323727. Bars above each data indicate standard 
deviation. 
Table 9 shows the level of significance of the methylation data of v.epi. tissue 
compared to all other tissues tested. 
v. epi. 9323727         
 
CpG1 CpG2 CpG3 CpG4 CpG5 
Blood 0 0 0 0.001 0.069 
Buccal 0 0 0 0 0.031 
Sperm 0 0 0 0 0.006 
Table 9. Levels of significance (p) for 9323727 
For all CpG sites of v. epi. marker compared to other tissues 
The p values of all CpG sites of v.epi. marker 9323727 were found to be below 
0.05 except CpG 5, indicating significant difference in percent methylation values. The 
epigenetic marker 9323727 was found to differentiate vaginal epithelial cells from blood, 
buccal, and sperm cells in four of the five sites studied (p<0.05). 
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CHAPTER V – DISCUSSION 
The importance of tissue identification cannot be overemphasized in the 
serological process in a criminal case.  Human identification through serological analysis 
and DNA profiling plays a critical role by supporting or rejecting an individual’s 
involvement in a crime based on the presence or absence of a suspect’s or victim’s DNA 
on probative evidentiary items.  Analysis of biological material in a criminal case serves 
to clarify the events that took place by distinguishing between casual and criminal contact 
between individuals.  For example, the presence or transfer of skin tissues or saliva may 
be taken as casual contact during a handshake or kiss, but the presence of blood or semen 
may suggest more intimate or violent contact.  Thus, the presence of a specific body fluid 
indicates the type of assault that may have occurred in criminal cases.  If the biological 
origin of an evidence item cannot be readily inferred, a test for discrimination between 
forensically-relevant tissues could significantly enhance the item’s probative value.  
Forensic identification of saliva, blood, and semen using methylation markers has been 
reported (Park et al 2014, Balamurugan et al 2014) but such markers for the identification 
of vaginal fluid are scarce. 
In this study we sought to analyze certain methylation markers that have the 
potential to distinguish vaginal fluid from other tissues such as blood, buccal cells, and 
sperm.  Several potential vaginal epithelial cell markers were reported by Park, et al., 
(2014) using Illumina human methylome 450K bead chip study, and we used this 
preliminary information to explore the extent to which those markers were useful in 
distinguishing vaginal fluid from other tissues. 
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Among several markers screened, a set of three epigenetic markers was identified 
that are promising for distinguishing vaginal epithelial cells from blood, buccal cells, and 
spermatozoa.  The three markers that were identified for differentiating v. epi. cells from 
other tissues were cg-6266993, cg-9323727, and cg-4739647.  These markers were 
identified by comparing the relative methylation levels of the four tissues studied using 
pyrosequencing. 
The methylation data for marker cg-6266993 shows that the v. epi. samples are 
hypermethylated in general while all other tissues were hypomethylated.  The data for 
this marker displayed a high standard deviation from the average when analyzed.  These 
high standard deviations are due to certain outliers in the sample population.  The 
methylation data for marker cg-9323727 also shows that the v. epi. samples are 
hypermethylated compared to other tissues that are hypomethylated.  The data also 
showed a relatively high standard deviation from the average, due to a couple of outlier 
samples in the sample pool.  The third marker cg-4739647 also shows that the v. epi. 
samples are hypermethylated in relation to the methylation levels of other tissues.  The 
differences between methylation levels of vaginal epithelial tissue and other tissues were 
statistically significant (p<0.05), suggesting that markers cg-6266993, cg-9323727, and 
cg-4739647 may be used to identify vaginal epithelial tissue, and the methylation 
differences are tissue-specific and not by chance. 
The study of epigenetic modifications of DNA and tissue specific methylation 
markers has received widespread attention among the forensic community in recent years 
(Frumkin, et al., 2011; Balamurugan, et al., 2014; Park, et al., 2014; Jenkins, et al., 2018).  
Epigenetics is a chemical process by which the gene expression is altered without 
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changing the genetic code of the gene involved.  Some areas of DNA undergo an 
epigenetic change known as methylation, which has been demonstrated to be conserved 
over time (Vidaki, et al., 2016; Lee, et al., 2012).  Appearing most often as a regulatory 
mechanism in the promoter region of genes, methylation is the addition of a methyl group 
(CH3) at the 5-carbon of a Cytosine (C) ring (followed by a Guanine-G), resulting in 5-
methylcytosine (5mC) (Kader & Ghai, 2015).  Because methylation is an epigenetic 
change, the methylation information is lost during the PCR process; performing bisulfite 
conversion of the DNA sample converts the unmethylated C to T, while the methylated C 
are not altered.  This ratio of converted/unconverted ‘C’ is used during the analysis to 
estimate the methylation status of a marker. 
In recent years, it has become evident that the momentum on the study of 
methylation markers for forensic purposes has been rapid and progressive.  Reliable 
methods have become available for the analysis of methylation and the level of 
methylation of a CpG site has been used to accurately predict the tissue source of a DNA 
sample; for example, blood and semen identification as reported by Frumkin, et al., 
(2011), Lee, et al., (2012), and Balamurugan, et.al., (2014).  These studies have 
successfully differentiated tissue types through differential methylation patterns and have 
served as forerunners for this current study. 
The advantages of these methylation markers for tissue identification are several-
fold.  First, DNA-based tissue differentiation circumvents the challenges of evidence that 
has been improperly stored or degraded since DNA is more stable than proteins and 
degrades at a slower rate.  Second, this method allows for the conservation of limited 
probative sample.  Once DNA is extracted from a sample in routine HID analysis, a small 
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amount of the extract can be used for tissue identification without consuming additional 
evidentiary material.  Third, bisulfite conversion and pyrosequencing can be performed 
with the existing lab equipment without any additional cost to the laboratory.  Fourth, this 
technology has the potential for automation and multiplexing, thereby reducing the time 
and the amount of sample expended.  The development of a universal methylation 
multiplex kit for forensic tissue and age identification is not too far away.  Since the 
pyrosequencing technology provides quantitative methylation data, it becomes easy to 
compare multiple samples and multiple tissues for their similarities and differences.  
Fifth, besides tissue identification, this pyrosequencing technology can also be used in the 
determination of the age of a sample donor, studies related to obesity, alcoholism, 
smoking, twin studies, and cancer research. 
Recently, the Illumina human methylome 450K bead chip has been used to study 
the overall methylation pattern of the entire human genome (Jenkins, et al. 2014, Lee, et 
al., 2015).  However, this study is very expensive and specific methylation quantitation 
values are not derived from the data.  Alternatively, the pyrosequencing technology 
provides the exact methylation quantitation values for each CpG site studied thereby 
making this technology more cost-efficient and a better forensic application. 
Evidence items can be subjected to harsh environmental conditions before 
collection and during storage.  Serological analysis of body fluid is carried out routinely 
using enzyme and protein markers, but exposure to heat, moisture, and the passage of 
time expedites the degradation of these proteins.  The detection of acid phosphatase in 
semen and amylase in saliva are two common examples involving those tests.  Studies 
involving mRNA profiling have also been reported, but again the tendency of mRNA to 
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degrade over time becomes problematic (Hass, et al., 2009).  To overcome these 
shortcomings, other reliable methods should be explored; one such method to be explored 
is the use of DNA methylation for tissue identification.  DNA degrades at a slower rate 
than enzymes, and partially-degraded DNA is still suitable for human identification 
(Edwards et al., 1991), thus making DNA a better candidate for tissue source attribution 
of biological evidence. 
In serological and DNA analysis, reducing the amount of probative sample 
expended for each test becomes priority.  Evidence conservation is also considered 
prudent as technology is ever-changing, and future innovations may be retroactively 
applied to unused portions of evidence.  This is evident by the fact that the previous DNA 
technology, Restriction Fragment Length Polymorphism (RFLP) required 100 ng or more 
DNA for analysis, while the current Polymerase Chain Reaction (PCR) technology 
requires only one nanogram of DNA samples to produce a complete DNA profile.  What 
was not possible two decades ago is possible today, thanks to the advancement in DNA 
technology as well as a rapid progress of computer applications. 
With an eye toward future research, the higher standard deviations caused by the 
outliers need to be explored to see if any other parameters such as age, smoking, obesity, 
or alcoholism may contribute to the differences in individual methylation values. Rando 
and Verstrepen (2007) have reported that epigenetic changes can occur due to 
environmental factors such as diet and smoking.  Several medical conditions and 
environmental factors such as obesity (de Mello et al., 2014), smoking (Besingi and 
Johansson, 2017), cancers, and age (Klutstein et. al. 2016; Jenkins et. al. 2018) are also 
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known to affect methylation levels.  Additional research may be needed to explore the 
ways in which these external factors affect methylation patters in different tissues. 
In conclusion, this study shows how DNA methylation can be used for 
differentiating one tissue from a variety of other bodily fluids.  All three markers detailed 
in this report were found to be hypermethylated in vaginal fluid, while the relative 
methylation levels of other tissues were hypomethylated.  Thus, the three markers 
reported herein have the potential to differentiate vaginal fluid from blood, saliva, and 
sperm samples. The full potential of these methylation markers needs to be explored 
further as they are not only a good indicator of the tissue source of DNA samples but can 
also be used to determine the age of the donor of the samples when the perpetrator is 
unknown. 
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APPENDIX A – Primer Specifications 
Marker Primer Sequence 
PCR Product 
Size 
CPG Site in 
Park Paper 
4739647 
Forward 
5’ ATGGTGGAGGTTGTAGTT 
Reverse 
5’ TCCCACCCAACATTACACTA 
Sequencing 
5’ GTGGAGGTTGTAGTTT 
89bp 4th 
6266993 
Forward 
5’ GGTGATTTTGGAGGGTTTGAT 
Reverse 
5’ AACCCCCCCCCCATATTTAA 
Sequencing 
5’ GGGTTTGATTTGTGGA 
137bp 4th 
9323727 
Forward 
5’ TGGGGAGATTGTAGTTTTTAAGT 
Reverse 
5’ ACCCCATTCCCTTCCTCCT 
Sequencing 
5’ GGGAATAAGTATTTTTAGGTTGG 
194bp 3rd 
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